Healthcare -
Biotechnology - NASDAQ - US
$ 18.05
2.67 %
$ 1.24 B
Market Cap
-3.77
P/E
ARVN - CASH & EQUIVALENTS
Cash & Equivalents ARVN - Arvinas, Inc.
312 M
LAST VALUE
69.65%
2 YEAR CAGR
150.03%
5 YEAR CAGR
0.00%
10 YEAR CAGR